article thumbnail

Medical Journals Refuse to Retract Fraudulent Trial Reports That Omitted Suicidal Events in Children

Mad in America

We cited research based on the clinical study reports the manufactures had submitted to drug regulators to get their drugs approved for children and adolescents and other research in our letter. 4,5 I asked Emslie and the manufacturer, Eli Lilly, if they wanted to restore the trials. The fraud was grave.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Four)

Mad in America

There was no placebo group, and all patients started on citalopram, manufactured by Lundbeck, which was motivated by horrendously erroneous claims of citalopram’s “absence of discontinuation symptoms” and its “safety” in elderly patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The American Journal of Psychiatry’s Answer to MIA: A Silence that Speaks Volumes

Mad in America

Pigott and colleagues published their first deconstruction of the trial in 2010, and in that publication and several others, they laid out the protocol violations that had been used to inflate the remission rate. Thus, this scandal is old news. The company developed a four-point message that needed to be told to the public.

article thumbnail

The Clinical, Social, and Cultural Harm of an Iatrogenic Psychiatry

Mad in America

The percentage of sexual dysfunction for SSRI antidepressants runs from 25%–73%, according to a 2010 examination of several studies (in one study of 344 patients who had a history of normal sexual function before SSRI treatments, there was an overall incidence of 58% sexual dysfunction).

article thumbnail

Review of Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule

Real Psychiatry

Supplementary 1: The more I thought about the figure quoted for precursor amounts used in the illicit manufacture of ketamine in China - the more skeptical I became. 2: UNODC, World Drug Report 2010 (United Nations Publication, Sales No. Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule. Washington DC. 2024; 295 pp.

article thumbnail

Upcoming ECT Legislation Needs to Be Revised

Mad in America

I am a 41-year-old resident of Newington since 2010, though I grew up in Middletown. Electroconvulsive Therapy, Manufacturers Liability, and Learned Intermediaries. MECTA Electroshock Device Manufacturer Files for Bankruptcy as its Shock Box Loses Liability Insurance. Dubey, 2023). 2022, June 19). link] Appelbaum, P. Gardner, H.,

article thumbnail

It’s You, It’s Not Me: Treatment Resistant Depression and the Psychiatric Breakup

Mad in America

But the person prescribing them (or manufacturing them) has a different problem to solve: explaining why I should still trust them to guide me to wellness. Manufacturing Depression: The Secret History of a Modern Disorder. If I am convinced that I will get better by taking antidepressants but then don’t, this creates dissonance.